Posted in | News | Iron Ore | Mining Business

Anglo American Looks to Sell Amapa Iron Ore Project

Anglo American is planning to sell its stake in the Amapa iron ore project in northern Brazil. It is considering selling its majority stake in the project so that it can concentrate on the development of its Minas - Rio project in the south of Brazil.

In 2008 the UK based Anglo American had acquired control of both the Amapa operation and Minas Rio from the Brazilian billionaire Eike Batista’s MMX. It had paid $5.5 billion for the acquisition. Now the company would rather focus on Minas Rio rather than the small Amapa iron ore mine in the Amazon.

The production from Amapa began in 2010 and it is expected to produce 4.5 million tones of iron ore in 2011. However at Minas Rio the projected production is likely to be 26.5 million tones of iron ore. Also now that Amapa has become profitable ahead of schedule other issues are also being considered.

The logistical problems with operations of the mine include the restriction of ore that can be shipped from the port in the Amazon that serves the mine at Amapa. The amount of ore is limited by the capsize vessels that can navigate the river system, this also increases the freight costs of the mine ore.

The remote location of the mine in the north also takes it away from the domestic market for iron ore in Brazil. Most of the country’s large steel mills which will buy the iron ore are located in the south which is closer to the Minas Rio project.

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Anglo American Plc. (2019, March 19). Anglo American Looks to Sell Amapa Iron Ore Project. AZoMining. Retrieved on February 25, 2024 from https://www.azomining.com/News.aspx?newsID=5639.

  • MLA

    Anglo American Plc. "Anglo American Looks to Sell Amapa Iron Ore Project". AZoMining. 25 February 2024. <https://www.azomining.com/News.aspx?newsID=5639>.

  • Chicago

    Anglo American Plc. "Anglo American Looks to Sell Amapa Iron Ore Project". AZoMining. https://www.azomining.com/News.aspx?newsID=5639. (accessed February 25, 2024).

  • Harvard

    Anglo American Plc. 2019. Anglo American Looks to Sell Amapa Iron Ore Project. AZoMining, viewed 25 February 2024, https://www.azomining.com/News.aspx?newsID=5639.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit
Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Azthena logo with the word Azthena

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.